Mesoblast.

No events began in the chosen period. Widen it, or reset.

• FDA Structural
  Helus Pharma is seeking review from the FDA for its drug candidate HLP003, led by company executive Eric So.
  Moves Mesoblast

  Wed 23:22
• United States Food and Drug Administration Structural
  Dr. Reddy's Laboratories' manufacturing facility in Visakhapatnam underwent a USFDA pre-approval inspection.
  Moves Mesoblast

  Thu 06:09
• Nasdaq Structural
  Direct Digital is voluntarily delisting from Nasdaq following SEC regulatory actions.
  Moves Mesoblast

  01:29
• Australian Securities Exchange Structural
  Firmus is seeking an IPO on the Australian Securities Exchange (ASX) while maintaining operational data centers in Singapore and Australia.
  Moves Mesoblast

  Wed 15:47
• Japan Shared context
  Japan selected Infleqtion, a Colorado-based company, as a foreign partner.
  Moves Mesoblast

  Wed 17:50
• Europe Shared context
  Protests are sweeping across Europe, with unrest observed in Lisbon, Spain, and France due to economic pressure.
  Moves Mesoblast

  03:05

• Silviu Itescu Structural

  Silviu Itescu founded Mesoblast and currently serves as its Chief Executive Officer.

  Well supportedAug 27
  Mesoblast → Silviu Itescu

  Silviu Itescu → Mesoblast
• FDA Structural

  Mesoblast's commercial function and product availability are dependent on regulatory approvals and oversight provided by the FDA.

  Some supportSep 24
  Mesoblast → FDA

  FDA → Mesoblast
• Nasdaq Structural

  Mesoblast is a publicly traded company listed on the Nasdaq stock exchange.

  Some supportSep 13
  Mesoblast → Nasdaq

  Nasdaq → Mesoblast
• United States Food and Drug Administration Structural

  The US FDA formally granted RMAT designation to Mesoblast, establishing a regulatory oversight relationship.

  Some supportJul 14
  Mesoblast → United States Food and Drug Administration

  United States Food and Drug Administration → Mesoblast
• Australian Securities Exchange Structural

  Mesoblast's shares are publicly traded on the Australian Securities Exchange.

  Some supportAug 17
  Mesoblast → Australian Securities Exchange

  Australian Securities Exchange → Mesoblast
• State Street Corporation Transactional

  State Street Corporation accumulated a 5.1% equity stake in Mesoblast as part of a specific investment transaction.

  Some supportAug 17
  Mesoblast → State Street Corporation

  State Street Corporation → Mesoblast
• Europe Shared context

  Mesoblast is seeking market access and regulatory approval within the European continent.

  Some supportAug 10
  Mesoblast → Europe

  Europe → Mesoblast
• Japan Shared context

  Mesoblast is seeking conditional regulatory approval for its lead product within Japan.

  Some supportJul 18
  Mesoblast → Japan

  Japan → Mesoblast